A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction
A legfontosabb adatok
- Ki végzi
- Negovsky Reanimatology Research Institute
- Hol
- Oroszország1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Leállítva
- Fázis
- 3. fázis
- Résztvevők
- 107 fő vett részt
- Kezdés
- 2021. nov. 20.
- Befejezés
- 2025. máj. 19.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport placebót (hatóanyag nélküli szert) kap, összehasonlításként.
- A vizsgált kezelések
- Lithium Carbonate
- Placebo
- A regiszteradat frissítve
- 2025. szeptember 25.
- Miért állt le
- Decision of the local ethics committee
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter összes feltétele (18)A regiszter feltételeinek elrejtése
Ki vehet részt
- age > 18 years
- elective carotid artery surgery
- general anesthesia
- written informed consent
Ki nem vehet részt
- urgent surgery
- Previously enrolled in this trial
- recent ( < 1 month) overt stroke
- The presence of any mental disorder according to the International Classification of Diseases 11th Revision which is confirmed by a psychiatrist
- The presence of any neuromuscular disease according to the International Classification of Diseases 11th Revision
- Hypersensitivity or known allergy to lithium carbonate
- History of seizure disorder
- History of leukemia
- Heart failure equal 3 or 4 class according to the New York Heart Association Functional Classification
- Left ventricular ejection fraction < 30%
- Mini-mental State Examination < 20 points
- Estimated glomerular filtration rate < 30 ml/min/1.73 m2
- Pregnant or breast-feeding women
- Inability to undergo a preoperative assessment for any reason
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
There are 10.3 million cases of stroke registered in the world every year; 63% of them lead to death. According to World Health Organization, stroke is one of the most important risk factors of death and early disability.
A teljes eredeti leírásKevesebb
Carotid artery surgery is a gold standard of hemodynamically significant carotid artery disease treatment. According to some trials, carotid artery surgery decreases the 2-years mortality.
The most important part of carotid artery surgery is a temporary absence of blood flow in the carotid artery. The duration of this period is a crucial characteristic of this type of surgery. The absence of blood flow leads to brain ischemia which is the risk factor of postoperative neurocognitive disorders such as emergence delirium, postoperative delirium and postoperative cognitive dysfunction.
Some surgical and non-surgical methods for brain protection were evaluated. According to recent data, there is no evidence of effective pharmacological protective methods that can decrease brain damage during carotid artery surgery.
Nevertheless, some trials demonstrated that using lithium-based medications for patients with a stroke can reduce the volume of the stroke. Therefore, the investigators want to check the hypothesis that using lithium-based medication in the preoperative period can reduce brain damage during carotid artery surgery.
The objectives of this trial:
1. To determine if Lithium carbonate is superior to placebo for the occurrence of emergence delirium, agitation, postoperative delirium and postoperative cognitive dysfunction. 2. To determine if Lithium carbonate is non-inferior to placebo for the occurrence of a new arrhythmia, leukocytosis, acute kidney injury, seizure disorders, diarrhea, nausea, and vomit.
A vizsgálat 2 csoportja
- LithiumA vizsgált kezelés
In preoperative period patients will take 300mg of lithium carbonate on 1-1-1 regimen during 2 days prior to surgery. On the day of surgery, they will take 300mg of lithium carbonate 2 hours before surgery. After the surgery, patients will take 300mg of lithium carbonate in the afternoon and 300mg of lithium carbonate in the evening.
Kezelés: Lithium Carbonate
- PlaceboPlacebo, összehasonlításként
In preoperative period patients will take placebo on 1-1-1 regimen during 2 days prior to surgery. On the day of surgery, they will take placebo 2 hours before surgery. After the surgery, patients will take placebo in the afternoon and in the evening.
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction: A Double-Blind, Placebo Control Randomized Trial (BINOS)
- A regiszteradat frissítve
- 2025. szeptember 25.